Shareable Research Card

ViewRay, Inc. Research and Development Expense

This metric view shows ViewRay, Inc. research and development expense history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q1 2023
Latest reported value
$8,628,000

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Mar 2023
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q1 2023.
  • Latest reported value on this page: $8,628,000.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Research and Development Expense

New fact period available

Latest reported research and development expense: $8,628,000. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Mar 2023

Page type

Metric history

Latest period

Q1 2023

SEC-backed company facts were refreshed from filings filed on 11 May 2023.

Benchmark Context

How Research and Development Expense compares with peers

ViewRay, Inc. is outside the visible top 120 companies for research and development expense in the current sample.

Compared with

Compared with 120 companies reporting research and development expense in USD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Research and Development Expense is up about 9.6% versus the comparable prior period.

  • Visible rows currently span reported period ends from 31 Dec 2010 to 28 Feb 2026.
  • Nearby companies in this sample: Alphabet Inc. and Meta Platforms, Inc..
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Plain-English Guide

What Research and Development Expense means

R&D expense is what the company reports spending on research and development during the period.

Why people care

It helps users understand how heavily the company is investing in future products, platforms, or technology.

How to read it

Compare R&D with revenue and operating income so you can see whether innovation spending is growing faster than the rest of the business.

Compare next

Compare it with revenue, operating income, and capex to understand the mix between current spending and long-term investment.

R&D intensity varies widely by industry, so peer comparisons are most useful when businesses are genuinely comparable.

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Financial Metric Page

ViewRay, Inc.: Research and Development Expense

Latest period: Q1 2023. Period end: 31 Mar 2023. Units: USD. Frequency: quarterly and annual.

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

What This Metric Tells You

  • Shows the reported level of research and development expense over 31 Dec 2013 - 31 Mar 2023.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 44 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.
  • Use the TTM line to smooth quarter-to-quarter noise.

Compare This Metric Across Companies

Compare latest available Research and Development Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Which companies spend the most on R&D?

Rank Company Latest value Reported period Next step
1 Alphabet Inc. (googl) $61,087,000,000 Year - 31 Dec 2025 Open Alphabet Inc. Research and Development Expense
2 Meta Platforms, Inc. (meta) $57,372,000,000 Year - 31 Dec 2025 Open Meta Platforms, Inc. Research and Development Expense
3 Merck & Co., Inc. (mrk) $15,789,000,000 Year - 31 Dec 2025 Open Merck & Co., Inc. Research and Development Expense
4 Apple Inc. (aapl) $10,887,000,000 Quarter - 27 Dec 2025 Open Apple Inc. Research and Development Expense
5 FORD MOTOR CO (f) $9,400,000,000 Year - 31 Dec 2025 Open FORD MOTOR CO Research and Development Expense
6 TOYOTA MOTOR CORP/ (tm) $8,585,000,000 Year - 31 Mar 2013 Open TOYOTA MOTOR CORP/ Research and Development Expense

Metric Details

Metric
Research and Development Expense (ResearchAndDevelopmentExpense)
Taxonomy
us-gaap
Units tracked
USD
Frequency coverage
quarterly and annual
History range
31 Dec 2013 - 31 Mar 2023
Facts on this page
44
Description
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Research and Development Expense, Trailing 12 Months (USD)
Research and Development Expense, Quarterly (USD)
Research and Development Expense, YoY Quarterly Change (%)
Research and Development Expense, Annual (USD)
Research and Development Expense, YoY Annual Change (%)

ViewRay, Inc. Quarterly Research and Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $33,189,000 $8,628,000 +$758,000 +9.6% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $32,431,000 $8,049,000 -$1,017,000 -11% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2023 2022 FY
Q3 2022 $33,448,000 $8,100,000 -$270,000 -3.2% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $33,718,000 $8,412,000 +$509,000 +6.4% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $33,209,000 $7,870,000 +$1,360,000 +21% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $31,849,000 $9,066,000 +$1,851,000 +26% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $29,998,000 $8,370,000 +$3,125,000 +60% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $26,873,000 $7,903,000 +$1,692,000 +27% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $25,181,000 $6,510,000 +$173,000 +2.7% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $25,008,000 $7,215,000 +$556,000 +8.4% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $24,452,000 $5,245,000 -$396,000 -7% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $24,848,000 $6,211,000 -$252,000 -3.9% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $25,100,000 $6,337,000 +$1,306,000 +26% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $23,794,000 $6,659,000 +$2,645,000 +66% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
Q3 2019 $21,149,000 $5,641,000 +$1,294,000 +30% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $19,855,000 $6,463,000 +$2,074,000 +47% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $17,781,000 $5,031,000 +$1,261,000 +33% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020 2020 Q1
Q4 2018 $16,520,000 $4,014,000 -$914,000 -19% 01 Oct 2018 31 Dec 2018 10-K 05 Mar 2021 2020 FY
Q3 2018 $17,434,000 $4,347,000 +$731,000 +20% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $16,703,000 $4,389,000 +$1,138,000 +35% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $15,565,000 $3,770,000 +$856,000 +29% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q4 2017 $14,709,000 $4,928,000 +$2,503,000 +103% 01 Oct 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
Q3 2017 $12,206,000 $3,616,000 +$962,000 +36% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $11,244,000 $3,251,000 +$287,000 +9.7% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $10,957,000 $2,914,000 -$485,000 -14% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $11,442,000 $2,425,000 -$616,000 -20% 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2019 2018 FY
Q3 2016 $12,058,000 $2,654,000 -$248,000 -8.5% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $12,306,000 $2,964,000 +$706,000 +31% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $11,600,000 $3,399,000 +$1,151,000 +51% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $10,449,000 $3,041,000 01 Oct 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
Q3 2015 $2,902,000 +$611,000 +27% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $2,258,000 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $2,248,000 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q3 2014 $2,291,000 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2015 Q3

ViewRay, Inc. Annual Research and Development Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $32,431,000 +$582,000 +1.8% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2023 2022 FY
2021 $31,849,000 +$6,841,000 +27% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
2020 $25,008,000 +$1,214,000 +5.1% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $23,794,000 +$7,274,000 +44% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $16,520,000 +$1,811,000 +12% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2021 2020 FY
2017 $14,709,000 +$3,267,000 +29% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $11,442,000 +$993,000 +9.5% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2019 2018 FY
2015 $10,449,000 +$1,045,000 +11% 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
2014 $9,404,000 +$624,000 +7.1% 01 Jan 2014 31 Dec 2014 10-K 17 Mar 2017 2016 FY
2013 $8,780,000 01 Jan 2013 31 Dec 2013 10-K 28 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.